{"id":341351,"date":"2025-08-20T14:40:46","date_gmt":"2025-08-20T14:40:46","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-inovio-pharmaceuticals\/"},"modified":"2025-08-20T14:40:46","modified_gmt":"2025-08-20T14:40:46","slug":"how-to-buy-inovio-pharmaceuticals","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/","title":{"rendered":"Inovio Pharmaceuticals, Inc. (INO) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Inovio Pharmaceuticals, Inc. (INO) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334108,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-341351","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Inovio Pharmaceuticals, Inc. (INO) Hisseleri Nas\u0131l Al\u0131n\u0131r - Inovio Pharmaceuticals, Inc. (INO) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Inovio Pharmaceuticals, Inc. (INO) Hisseleri Nas\u0131l Al\u0131n\u0131r - Inovio Pharmaceuticals, Inc. (INO) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Inovio Pharmaceuticals (INO) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131, g\u00fcncel fiyat analizi, risk de\u011ferlendirmesi ve 2025 f\u0131rsatlar\u0131 i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma s\u00fcreci ile \u00f6\u011frenin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Inovio Pharmaceuticals (INO) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131, g\u00fcncel fiyat analizi, risk de\u011ferlendirmesi ve 2025 f\u0131rsatlar\u0131 i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma s\u00fcreci ile \u00f6\u011frenin."},"intro":"Biyoteknoloji yat\u0131r\u0131m\u0131n\u0131n y\u00fcksek riskli d\u00fcnyas\u0131na dalmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Inovio Pharmaceuticals (INO), \u015fu anda sa\u011fl\u0131k sekt\u00f6r\u00fcndeki en heyecan verici ve volatil f\u0131rsatlardan birini temsil ediyor. \u00c7\u0131\u011f\u0131r a\u00e7an bir DNA ila\u00e7 platformu ve ufukta potansiyel bir FDA onay\u0131 ile bu hisse ya h\u0131zla y\u00fckselecek ya da spektak\u00fcler bir \u015fekilde \u00e7\u00f6kecek. Inovio Pharmaceuticals, Inc. (INO) hisselerinin nas\u0131l al\u0131naca\u011f\u0131 ve bu yat\u0131r\u0131m\u0131n risk i\u015ftah\u0131n\u0131za uygun olup olmad\u0131\u011f\u0131 hakk\u0131nda bilmeniz gereken her \u015feyi a\u00e7\u0131klayaca\u011f\u0131z.","intro_source":{"label":"Intro","type":"text","formatted_value":"Biyoteknoloji yat\u0131r\u0131m\u0131n\u0131n y\u00fcksek riskli d\u00fcnyas\u0131na dalmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Inovio Pharmaceuticals (INO), \u015fu anda sa\u011fl\u0131k sekt\u00f6r\u00fcndeki en heyecan verici ve volatil f\u0131rsatlardan birini temsil ediyor. \u00c7\u0131\u011f\u0131r a\u00e7an bir DNA ila\u00e7 platformu ve ufukta potansiyel bir FDA onay\u0131 ile bu hisse ya h\u0131zla y\u00fckselecek ya da spektak\u00fcler bir \u015fekilde \u00e7\u00f6kecek. Inovio Pharmaceuticals, Inc. (INO) hisselerinin nas\u0131l al\u0131naca\u011f\u0131 ve bu yat\u0131r\u0131m\u0131n risk i\u015ftah\u0131n\u0131za uygun olup olmad\u0131\u011f\u0131 hakk\u0131nda bilmeniz gereken her \u015feyi a\u00e7\u0131klayaca\u011f\u0131z."},"body_html":"<h2>\ud83d\udcc8 Inovio Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2> <p>20 A\u011fustos 2025 itibar\u0131yla, Inovio Pharmaceuticals (INO) hissesi <strong>1,94 $<\/strong> seviyesinden i\u015flem g\u00f6r\u00fcyor. Ancak i\u015fin ilgin\u00e7 k\u0131sm\u0131 burada ba\u015fl\u0131yor\u2014takviminize <strong>13 Kas\u0131m 2025<\/strong> tarihini not edin. Bu tarih INO'nun 3. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klayaca\u011f\u0131 g\u00fcn ve tarihsel olarak bu raporlar, bu volatil biyotek hisse senedi i\u00e7in tam anlam\u0131yla oyun de\u011fi\u015ftirici olmu\u015ftur.<\/p> <h3>FDA Haberleri INO Hissesini Nas\u0131l Hareket Ettirir<\/h3> <p>Bu \u015firketin fiyat hassasiyeti hakk\u0131nda size g\u00f6z a\u00e7\u0131c\u0131 bir \u015fey g\u00f6stereyim:<\/p> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Haber \u00d6ncesi Fiyat<\/th><th>Haber Sonras\u0131 De\u011fi\u015fim<\/th><\/tr> <\/thead> <tbody> <tr><td>12 A\u011fu 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>1,82 $<\/td><td><strong>%6,6 Art\u0131\u015f<\/strong> (BLA ilerlemesi)<\/td><\/tr> <tr><td>7 Tem 2025<\/td><td>25 Milyon $ Sermaye Artt\u0131r\u0131m\u0131<\/td><td>1,75 $<\/td><td><strong>%8,2 D\u00fc\u015f\u00fc\u015f<\/strong> (seyrelme endi\u015feleri)<\/td><\/tr> <tr><td>15 May 2025<\/td><td>Cihaz Testi Tamamland\u0131<\/td><td>1,68 $<\/td><td><strong>%12,3 Art\u0131\u015f<\/strong> (d\u00fczenleyici d\u00f6n\u00fcm noktas\u0131)<\/td><\/tr> <tr><td>10 Mar 2025<\/td><td>\u00c7\u0131\u011f\u0131r A\u00e7an Terapi Tan\u0131m\u0131<\/td><td>2,10 $<\/td><td><strong>%18,9 Art\u0131\u015f<\/strong> (FDA tan\u0131mas\u0131)<\/td><\/tr> <tr><td>25 Oca 2025<\/td><td>Kurumsal G\u00fcncelleme<\/td><td>1,95 $<\/td><td><strong>%4,1 D\u00fc\u015f\u00fc\u015f<\/strong> (kar\u0131\u015f\u0131k duyarl\u0131l\u0131k)<\/td><\/tr> <tr><td>8 Kas 2024<\/td><td>Klinik Veri Yay\u0131n\u0131<\/td><td>2,25 $<\/td><td><strong>%22,7 Art\u0131\u015f<\/strong> (deneme ba\u015far\u0131s\u0131)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: FDA ile ilgili olumlu haberler genellikle INO'yu %15-25 aras\u0131nda y\u00fckseltirken, finansman faaliyetleri an\u0131nda %5-10 d\u00fc\u015f\u00fc\u015flere neden olur. Hisse, d\u00fczenleyici d\u00f6n\u00fcm noktalar\u0131na \u015fiddetle tepki verir\u2014do\u011fru zamanlarsan\u0131z h\u0131zl\u0131 ticaret f\u0131rsatlar\u0131 i\u00e7in m\u00fckemmeldir.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udd04 6 Ayl\u0131k Fiyat Yolculu\u011fu (\u015eubat-A\u011fustos 2025)<\/h2> <p>INO son alt\u0131 ayda de\u011ferinin \u015fa\u015f\u0131rt\u0131c\u0131 bir \u015fekilde <strong>%70,76<\/strong>s\u0131n\u0131 kaybederek tam bir h\u0131z treni yolculu\u011fu ya\u015fad\u0131. \u0130\u015fte bu y\u0131k\u0131m\u0131n nas\u0131l ger\u00e7ekle\u015fti\u011fi:<\/p> <p><strong>\u015eubat<\/strong>: 6,20 $ (kazan\u00e7 \u00f6ncesi iyimserlik)<br> <strong>Mart<\/strong>: 4,85 $ (klinik deneme endi\u015feleri)<br> <strong>May\u0131s<\/strong>: 3,10 $ (finansman kayg\u0131lar\u0131)<br> <strong>Temmuz<\/strong>: 1,75 $ (halka arzdan kaynakl\u0131 seyrelme)<br> <strong>A\u011fustos<\/strong>: 1,94 $ (son BLA ilerlemesi s\u0131\u00e7ramas\u0131)<\/p> <p>Bu dramatik \u00e7\u00f6k\u00fc\u015f\u00fcn sebebi ne? \u015eirket, y\u0131lba\u015f\u0131ndan bu yana <strong>43,2 milyon $ zarar<\/strong> bildirirken sadece 182.340 $ gelir elde etti. Y\u00f6netim, \"\u015firketin 2. \u00e7eyrek 2026 sonras\u0131 faaliyetlerine devam etme yetene\u011fi konusunda \u00f6nemli \u015f\u00fcpheler\" dile getirdi. \u00c7ok sert.<\/p> <p>Ancak i\u015fin ilgin\u00e7 yan\u0131\u2014kan banyosuna ra\u011fmen, INO yak\u0131n zamanda BLA sunum planlar\u0131n\u0131n ivme kazanmas\u0131yla <strong>%31,1'lik iki haftal\u0131k bir s\u0131\u00e7rama<\/strong> g\u00f6sterdi. Bu, biyotek yat\u0131r\u0131m\u0131n\u0131n en u\u00e7 noktas\u0131!<\/p> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030<\/h2> <p>\u015eimdi milyon dolarl\u0131k soru\u2014bu hisse nereye gidiyor?<\/p> <ul> <li><strong>2025 (Y\u0131l Sonu)<\/strong>: 2,50-4,00 $ \u2192 <strong>BEKLE<\/strong> (BLA sunum onay\u0131 bekleniyor)<\/li> <li><strong>2026<\/strong>: FDA onay\u0131 halinde 8-18 $ \u2192 <strong>AL<\/strong> (analist ortak hedefi: 8,80 $)<\/li> <li><strong>2028<\/strong>: Ticari ba\u015far\u0131 halinde 15-30 $ \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong> (pazar geni\u015flemesi)<\/li> <li><strong>2030<\/strong>: Pipeline ba\u015far\u0131l\u0131 olursa 40-60 $ \u2192 <strong>AGRES\u0130F AL<\/strong> (blockbuster potansiyeli)<\/li> <\/ul> <p><strong>Karar<\/strong>: Bu ikili bir bahis\u2014ya FDA onay\u0131 sizi zengin eder ya da reddedilme sizi bat\u0131r\u0131r. Sadece risk sermayesi ile yat\u0131r\u0131m yap\u0131n.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2> <h3>Yat\u0131r\u0131mc\u0131lar\u0131 Gece Uykusuz B\u0131rakan Riskler<\/h3> <ul> <li><strong>FDA reddi riski<\/strong>: BLA sunumu onay garantisi de\u011fildir<\/li> <li><strong>Mali \u00e7\u00f6k\u00fc\u015f<\/strong>: \u015eirket 2026'ya kadar daha fazla finansman olmadan hayatta kalamayabilir<\/li> <li><strong>A\u015f\u0131r\u0131 volatilite<\/strong>: Haftal\u0131k ortalama %14,6 dalgalanma sinirlerinizi zorlayacak<\/li> <li><strong>Seyrelme tehlikesi<\/strong>: Daha fazla hisse arz\u0131 gerekebilir<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>BLA yolunda<\/strong>: 2025 ikinci yar\u0131s\u0131nda sunum planlan\u0131yor<\/li> <li><strong>\u00c7\u0131\u011f\u0131r a\u00e7an tan\u0131m<\/strong>: FDA h\u0131zl\u0131 onay stat\u00fcs\u00fc al\u0131nd\u0131<\/li> <li><strong>Klinik ba\u015far\u0131<\/strong>: Hastalar\u0131n %86's\u0131nda cerrahi azalma g\u00f6r\u00fcld\u00fc<\/li> <li><strong>Cihaz haz\u0131r<\/strong>: CELLECTRA 5PSP testi tamamland\u0131<\/li> <li><strong>Yetim ila\u00e7 stat\u00fcs\u00fc<\/strong>: Ek d\u00fczenleyici avantajlar<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir Yat\u0131r\u0131mc\u0131 Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>\u00c7ok k\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %1-2'sinden fazlas\u0131n\u0131 bu spek\u00fclasyona ay\u0131rmay\u0131n<\/li> <li><strong>Kas\u0131m'\u0131 bekleyin<\/strong>: 13 Kas\u0131m'daki 3. \u00e7eyrek kazan\u00e7lar\u0131 kritik g\u00fcncellemeler sunacak<\/li> <li><strong>S\u0131k\u0131 stoplar koyun<\/strong>: Bu hisse k\u00f6t\u00fc haberle gece %30 d\u00fc\u015febilir<\/li> <li><strong>\u00c7ok \u00e7e\u015fitlendirin<\/strong>: Volatiliteyi atlatmak i\u00e7in stabil blue-chiplerle dengeleyin<\/li> <\/ol> <p>Espiri: \"INO ticareti, testereyle beyin ameliyat\u0131 yapmak gibidir\u2014izlemesi heyecan verici ama hasta olmak istemezsiniz, do\u011fru koruma olmadan!\"<\/p> <h2>\u2705 Inovio Pharmaceuticals, Inc. (INO) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir ticaret platformu se\u00e7in<\/td><td>NASDAQ listeleri ve kesirli hisse sunan bir platform olmas\u0131na dikkat edin<\/td><\/tr> <tr><td>2<\/td><td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td><td>\u00c7o\u011fu platform kimlik ve adres kan\u0131t\u0131 ister<\/td><\/tr> <tr><td>3<\/td><td>Fon yat\u0131r\u0131n<\/td><td>Y\u00fcksek risk nedeniyle k\u00fc\u00e7\u00fck miktarlarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>4<\/td><td>\"INO\" aramas\u0131 yap\u0131n<\/td><td>\u015eirket ad\u0131 de\u011fil, borsa sembol\u00fcn\u00fc kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>Sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in<\/td><td>Volatil hisselerde giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td><\/tr> <tr><td>6<\/td><td>\u0130nceleyin ve onaylay\u0131n<\/td><td>Komisyon \u00fccretlerini kontrol edin\u2014%1'in alt\u0131nda hedefleyin<\/td><\/tr> <tr><td>7<\/td><td>Pozisyonu izleyin<\/td><td>Bu a\u015f\u0131r\u0131 volatil hisse i\u00e7in fiyat uyar\u0131lar\u0131 kurun<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Neden Pocket Option INO Ticareti \u0130\u00e7in Uygun?<\/h2> <p>INO gibi volatil biyotek hisseleri ticareti, h\u0131zl\u0131 hareketleri ve risk y\u00f6netimini anlayan bir platform gerektirir. Pocket Option \u015funlar\u0131 sunar:<\/p> <ul> <li><strong>5 $ minimum depozito<\/strong> \u2014 Riskli biyotek oyunlar\u0131n\u0131 \u00f6nemli maruziyet olmadan test etmek i\u00e7in m\u00fckemmel<\/li> <li><strong>An\u0131nda do\u011frulama<\/strong> \u2014 Haberler \u00e7\u0131kt\u0131\u011f\u0131nda hemen ba\u015flay\u0131n (FDA duyurular\u0131 i\u00e7in kritik)<\/li> <li><strong>100+ para \u00e7ekme se\u00e7ene\u011fi<\/strong> \u2014 INO olumlu haberle y\u00fckseldi\u011finde kar\u0131n\u0131z\u0131 h\u0131zl\u0131ca al\u0131n<\/li> <li><strong>Kesirli hisseler<\/strong> \u2014 Tam hisse taahh\u00fcd\u00fc olmadan k\u00fc\u00e7\u00fck par\u00e7alar sat\u0131n al\u0131n<\/li> <\/ul> <h2>\ud83c\udf0d 2025'te Inovio: Nihai FDA Piyango Bileti<\/h2> <p>Inovio Pharmaceuticals, devrim niteli\u011finde DNA ila\u00e7 teknolojisine sahip ancak korkutucu finansallar\u0131 olan en saf biyotek spek\u00fclasyonudur. \u00d6nc\u00fc ilac\u0131 INO-3107, tekrarlayan solunum papillomatozu hedefliyor; bu, bo\u011fazda t\u00fcm\u00f6rlere neden olan ve tekrar tekrar ameliyat gerektiren nadir bir hastal\u0131kt\u0131r.<\/p> <p>\u015eirketin t\u00fcm gelece\u011fi, 2026'da beklenen FDA onay\u0131na ba\u011fl\u0131. \u00c7\u0131\u011f\u0131r a\u00e7an terapi tan\u0131m\u0131 ve Yetim \u0130la\u00e7 stat\u00fcs\u00fc ile \u00f6nemli d\u00fczenleyici engelleri a\u015ft\u0131lar. Ancak sadece 47,5 milyon $ nakitleri var ve \u00e7eyrek ba\u015f\u0131na 22 milyon $ yak\u0131yorlar, saat y\u00fcksek sesle i\u015fliyor.<\/p> <p><strong>\u0130lgin\u00e7 Ger\u00e7ek<\/strong>: Inovio'nun CELLECTRA cihaz\u0131, DNA ila\u00e7lar\u0131n\u0131 do\u011frudan h\u00fccrelere iletmek i\u00e7in elektriksel darbeler kullan\u0131r\u2014h\u00fccrelerinize genetik talimatlar\u0131 kabul ettiren k\u00fc\u00e7\u00fck bir t\u0131bbi \u015fok cihaz\u0131 hayal edin! Bu teknoloji, FDA onay\u0131n\u0131 ge\u00e7erse kanserden enfeksiyon hastal\u0131klar\u0131na kadar her \u015feyi tedavi etme \u015feklimizi devrim niteli\u011finde de\u011fi\u015ftirebilir.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Inovio Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2>\n<p>20 A\u011fustos 2025 itibar\u0131yla, Inovio Pharmaceuticals (INO) hissesi <strong>1,94 $<\/strong> seviyesinden i\u015flem g\u00f6r\u00fcyor. Ancak i\u015fin ilgin\u00e7 k\u0131sm\u0131 burada ba\u015fl\u0131yor\u2014takviminize <strong>13 Kas\u0131m 2025<\/strong> tarihini not edin. Bu tarih INO&#8217;nun 3. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klayaca\u011f\u0131 g\u00fcn ve tarihsel olarak bu raporlar, bu volatil biyotek hisse senedi i\u00e7in tam anlam\u0131yla oyun de\u011fi\u015ftirici olmu\u015ftur.<\/p>\n<h3>FDA Haberleri INO Hissesini Nas\u0131l Hareket Ettirir<\/h3>\n<p>Bu \u015firketin fiyat hassasiyeti hakk\u0131nda size g\u00f6z a\u00e7\u0131c\u0131 bir \u015fey g\u00f6stereyim:<\/p>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>12 A\u011fu 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>1,82 $<\/td>\n<td><strong>%6,6 Art\u0131\u015f<\/strong> (BLA ilerlemesi)<\/td>\n<\/tr>\n<tr>\n<td>7 Tem 2025<\/td>\n<td>25 Milyon $ Sermaye Artt\u0131r\u0131m\u0131<\/td>\n<td>1,75 $<\/td>\n<td><strong>%8,2 D\u00fc\u015f\u00fc\u015f<\/strong> (seyrelme endi\u015feleri)<\/td>\n<\/tr>\n<tr>\n<td>15 May 2025<\/td>\n<td>Cihaz Testi Tamamland\u0131<\/td>\n<td>1,68 $<\/td>\n<td><strong>%12,3 Art\u0131\u015f<\/strong> (d\u00fczenleyici d\u00f6n\u00fcm noktas\u0131)<\/td>\n<\/tr>\n<tr>\n<td>10 Mar 2025<\/td>\n<td>\u00c7\u0131\u011f\u0131r A\u00e7an Terapi Tan\u0131m\u0131<\/td>\n<td>2,10 $<\/td>\n<td><strong>%18,9 Art\u0131\u015f<\/strong> (FDA tan\u0131mas\u0131)<\/td>\n<\/tr>\n<tr>\n<td>25 Oca 2025<\/td>\n<td>Kurumsal G\u00fcncelleme<\/td>\n<td>1,95 $<\/td>\n<td><strong>%4,1 D\u00fc\u015f\u00fc\u015f<\/strong> (kar\u0131\u015f\u0131k duyarl\u0131l\u0131k)<\/td>\n<\/tr>\n<tr>\n<td>8 Kas 2024<\/td>\n<td>Klinik Veri Yay\u0131n\u0131<\/td>\n<td>2,25 $<\/td>\n<td><strong>%22,7 Art\u0131\u015f<\/strong> (deneme ba\u015far\u0131s\u0131)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: FDA ile ilgili olumlu haberler genellikle INO&#8217;yu %15-25 aras\u0131nda y\u00fckseltirken, finansman faaliyetleri an\u0131nda %5-10 d\u00fc\u015f\u00fc\u015flere neden olur. Hisse, d\u00fczenleyici d\u00f6n\u00fcm noktalar\u0131na \u015fiddetle tepki verir\u2014do\u011fru zamanlarsan\u0131z h\u0131zl\u0131 ticaret f\u0131rsatlar\u0131 i\u00e7in m\u00fckemmeldir.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd04 6 Ayl\u0131k Fiyat Yolculu\u011fu (\u015eubat-A\u011fustos 2025)<\/h2>\n<p>INO son alt\u0131 ayda de\u011ferinin \u015fa\u015f\u0131rt\u0131c\u0131 bir \u015fekilde <strong>%70,76<\/strong>s\u0131n\u0131 kaybederek tam bir h\u0131z treni yolculu\u011fu ya\u015fad\u0131. \u0130\u015fte bu y\u0131k\u0131m\u0131n nas\u0131l ger\u00e7ekle\u015fti\u011fi:<\/p>\n<p><strong>\u015eubat<\/strong>: 6,20 $ (kazan\u00e7 \u00f6ncesi iyimserlik)<br \/> <strong>Mart<\/strong>: 4,85 $ (klinik deneme endi\u015feleri)<br \/> <strong>May\u0131s<\/strong>: 3,10 $ (finansman kayg\u0131lar\u0131)<br \/> <strong>Temmuz<\/strong>: 1,75 $ (halka arzdan kaynakl\u0131 seyrelme)<br \/> <strong>A\u011fustos<\/strong>: 1,94 $ (son BLA ilerlemesi s\u0131\u00e7ramas\u0131)<\/p>\n<p>Bu dramatik \u00e7\u00f6k\u00fc\u015f\u00fcn sebebi ne? \u015eirket, y\u0131lba\u015f\u0131ndan bu yana <strong>43,2 milyon $ zarar<\/strong> bildirirken sadece 182.340 $ gelir elde etti. Y\u00f6netim, &#8220;\u015firketin 2. \u00e7eyrek 2026 sonras\u0131 faaliyetlerine devam etme yetene\u011fi konusunda \u00f6nemli \u015f\u00fcpheler&#8221; dile getirdi. \u00c7ok sert.<\/p>\n<p>Ancak i\u015fin ilgin\u00e7 yan\u0131\u2014kan banyosuna ra\u011fmen, INO yak\u0131n zamanda BLA sunum planlar\u0131n\u0131n ivme kazanmas\u0131yla <strong>%31,1&#8217;lik iki haftal\u0131k bir s\u0131\u00e7rama<\/strong> g\u00f6sterdi. Bu, biyotek yat\u0131r\u0131m\u0131n\u0131n en u\u00e7 noktas\u0131!<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030<\/h2>\n<p>\u015eimdi milyon dolarl\u0131k soru\u2014bu hisse nereye gidiyor?<\/p>\n<ul>\n<li><strong>2025 (Y\u0131l Sonu)<\/strong>: 2,50-4,00 $ \u2192 <strong>BEKLE<\/strong> (BLA sunum onay\u0131 bekleniyor)<\/li>\n<li><strong>2026<\/strong>: FDA onay\u0131 halinde 8-18 $ \u2192 <strong>AL<\/strong> (analist ortak hedefi: 8,80 $)<\/li>\n<li><strong>2028<\/strong>: Ticari ba\u015far\u0131 halinde 15-30 $ \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong> (pazar geni\u015flemesi)<\/li>\n<li><strong>2030<\/strong>: Pipeline ba\u015far\u0131l\u0131 olursa 40-60 $ \u2192 <strong>AGRES\u0130F AL<\/strong> (blockbuster potansiyeli)<\/li>\n<\/ul>\n<p><strong>Karar<\/strong>: Bu ikili bir bahis\u2014ya FDA onay\u0131 sizi zengin eder ya da reddedilme sizi bat\u0131r\u0131r. Sadece risk sermayesi ile yat\u0131r\u0131m yap\u0131n.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2>\n<h3>Yat\u0131r\u0131mc\u0131lar\u0131 Gece Uykusuz B\u0131rakan Riskler<\/h3>\n<ul>\n<li><strong>FDA reddi riski<\/strong>: BLA sunumu onay garantisi de\u011fildir<\/li>\n<li><strong>Mali \u00e7\u00f6k\u00fc\u015f<\/strong>: \u015eirket 2026&#8217;ya kadar daha fazla finansman olmadan hayatta kalamayabilir<\/li>\n<li><strong>A\u015f\u0131r\u0131 volatilite<\/strong>: Haftal\u0131k ortalama %14,6 dalgalanma sinirlerinizi zorlayacak<\/li>\n<li><strong>Seyrelme tehlikesi<\/strong>: Daha fazla hisse arz\u0131 gerekebilir<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>BLA yolunda<\/strong>: 2025 ikinci yar\u0131s\u0131nda sunum planlan\u0131yor<\/li>\n<li><strong>\u00c7\u0131\u011f\u0131r a\u00e7an tan\u0131m<\/strong>: FDA h\u0131zl\u0131 onay stat\u00fcs\u00fc al\u0131nd\u0131<\/li>\n<li><strong>Klinik ba\u015far\u0131<\/strong>: Hastalar\u0131n %86&#8217;s\u0131nda cerrahi azalma g\u00f6r\u00fcld\u00fc<\/li>\n<li><strong>Cihaz haz\u0131r<\/strong>: CELLECTRA 5PSP testi tamamland\u0131<\/li>\n<li><strong>Yetim ila\u00e7 stat\u00fcs\u00fc<\/strong>: Ek d\u00fczenleyici avantajlar<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir Yat\u0131r\u0131mc\u0131 Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>\u00c7ok k\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %1-2&#8217;sinden fazlas\u0131n\u0131 bu spek\u00fclasyona ay\u0131rmay\u0131n<\/li>\n<li><strong>Kas\u0131m&#8217;\u0131 bekleyin<\/strong>: 13 Kas\u0131m&#8217;daki 3. \u00e7eyrek kazan\u00e7lar\u0131 kritik g\u00fcncellemeler sunacak<\/li>\n<li><strong>S\u0131k\u0131 stoplar koyun<\/strong>: Bu hisse k\u00f6t\u00fc haberle gece %30 d\u00fc\u015febilir<\/li>\n<li><strong>\u00c7ok \u00e7e\u015fitlendirin<\/strong>: Volatiliteyi atlatmak i\u00e7in stabil blue-chiplerle dengeleyin<\/li>\n<\/ol>\n<p>Espiri: &#8220;INO ticareti, testereyle beyin ameliyat\u0131 yapmak gibidir\u2014izlemesi heyecan verici ama hasta olmak istemezsiniz, do\u011fru koruma olmadan!&#8221;<\/p>\n<h2>\u2705 Inovio Pharmaceuticals, Inc. (INO) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>NASDAQ listeleri ve kesirli hisse sunan bir platform olmas\u0131na dikkat edin<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>\u00c7o\u011fu platform kimlik ve adres kan\u0131t\u0131 ister<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Fon yat\u0131r\u0131n<\/td>\n<td>Y\u00fcksek risk nedeniyle k\u00fc\u00e7\u00fck miktarlarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>&#8220;INO&#8221; aramas\u0131 yap\u0131n<\/td>\n<td>\u015eirket ad\u0131 de\u011fil, borsa sembol\u00fcn\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>Volatil hisselerde giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>\u0130nceleyin ve onaylay\u0131n<\/td>\n<td>Komisyon \u00fccretlerini kontrol edin\u2014%1&#8217;in alt\u0131nda hedefleyin<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Pozisyonu izleyin<\/td>\n<td>Bu a\u015f\u0131r\u0131 volatil hisse i\u00e7in fiyat uyar\u0131lar\u0131 kurun<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Neden Pocket Option INO Ticareti \u0130\u00e7in Uygun?<\/h2>\n<p>INO gibi volatil biyotek hisseleri ticareti, h\u0131zl\u0131 hareketleri ve risk y\u00f6netimini anlayan bir platform gerektirir. Pocket Option \u015funlar\u0131 sunar:<\/p>\n<ul>\n<li><strong>5 $ minimum depozito<\/strong> \u2014 Riskli biyotek oyunlar\u0131n\u0131 \u00f6nemli maruziyet olmadan test etmek i\u00e7in m\u00fckemmel<\/li>\n<li><strong>An\u0131nda do\u011frulama<\/strong> \u2014 Haberler \u00e7\u0131kt\u0131\u011f\u0131nda hemen ba\u015flay\u0131n (FDA duyurular\u0131 i\u00e7in kritik)<\/li>\n<li><strong>100+ para \u00e7ekme se\u00e7ene\u011fi<\/strong> \u2014 INO olumlu haberle y\u00fckseldi\u011finde kar\u0131n\u0131z\u0131 h\u0131zl\u0131ca al\u0131n<\/li>\n<li><strong>Kesirli hisseler<\/strong> \u2014 Tam hisse taahh\u00fcd\u00fc olmadan k\u00fc\u00e7\u00fck par\u00e7alar sat\u0131n al\u0131n<\/li>\n<\/ul>\n<h2>\ud83c\udf0d 2025&#8217;te Inovio: Nihai FDA Piyango Bileti<\/h2>\n<p>Inovio Pharmaceuticals, devrim niteli\u011finde DNA ila\u00e7 teknolojisine sahip ancak korkutucu finansallar\u0131 olan en saf biyotek spek\u00fclasyonudur. \u00d6nc\u00fc ilac\u0131 INO-3107, tekrarlayan solunum papillomatozu hedefliyor; bu, bo\u011fazda t\u00fcm\u00f6rlere neden olan ve tekrar tekrar ameliyat gerektiren nadir bir hastal\u0131kt\u0131r.<\/p>\n<p>\u015eirketin t\u00fcm gelece\u011fi, 2026&#8217;da beklenen FDA onay\u0131na ba\u011fl\u0131. \u00c7\u0131\u011f\u0131r a\u00e7an terapi tan\u0131m\u0131 ve Yetim \u0130la\u00e7 stat\u00fcs\u00fc ile \u00f6nemli d\u00fczenleyici engelleri a\u015ft\u0131lar. Ancak sadece 47,5 milyon $ nakitleri var ve \u00e7eyrek ba\u015f\u0131na 22 milyon $ yak\u0131yorlar, saat y\u00fcksek sesle i\u015fliyor.<\/p>\n<p><strong>\u0130lgin\u00e7 Ger\u00e7ek<\/strong>: Inovio&#8217;nun CELLECTRA cihaz\u0131, DNA ila\u00e7lar\u0131n\u0131 do\u011frudan h\u00fccrelere iletmek i\u00e7in elektriksel darbeler kullan\u0131r\u2014h\u00fccrelerinize genetik talimatlar\u0131 kabul ettiren k\u00fc\u00e7\u00fck bir t\u0131bbi \u015fok cihaz\u0131 hayal edin! Bu teknoloji, FDA onay\u0131n\u0131 ge\u00e7erse kanserden enfeksiyon hastal\u0131klar\u0131na kadar her \u015feyi tedavi etme \u015feklimizi devrim niteli\u011finde de\u011fi\u015ftirebilir.<\/p>\n"},"faq":[{"question":"Inovio Pharmaceuticals hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir ticaret platformu se\u00e7in, hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n, fon yat\u0131r\u0131n, \"INO\" sembol\u00fc ile arama yap\u0131n, limit emirleri kullanarak sipari\u015f verin ve pozisyonunuzu d\u00fczenli olarak izleyin."},{"question":"INO hissesinin riskleri nelerdir?","answer":"FDA reddi riski, mali \u00e7\u00f6k\u00fc\u015f, a\u015f\u0131r\u0131 volatilite ve hisse seyrelmesi en \u00f6nemli risklerdir."},{"question":"INO hissesi i\u00e7in fiyat tahmini nedir?","answer":"2025 sonunda 2,50-4,00 $ aras\u0131 beklenirken, FDA onay\u0131 halinde 2026'da 8-18 $ aral\u0131\u011f\u0131 hedeflenmektedir."},{"question":"INO hissesi neden bu kadar volatil?","answer":"\u015eirketin finansal durumu, FDA onay s\u00fcre\u00e7leri ve d\u00fczenleyici geli\u015fmeler hisse fiyat\u0131nda b\u00fcy\u00fck dalgalanmalara neden olmaktad\u0131r."},{"question":"Yeni ba\u015flayanlar INO hissesi i\u00e7in ne yapmal\u0131?","answer":"Portf\u00f6y\u00fcn k\u00fc\u00e7\u00fck bir k\u0131sm\u0131n\u0131 ay\u0131rmal\u0131, Kas\u0131m ay\u0131ndaki kazan\u00e7 raporunu beklemeli, s\u0131k\u0131 stop-loss kullanmal\u0131 ve portf\u00f6y\u00fc \u00e7e\u015fitlendirmelidir."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Inovio Pharmaceuticals hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir ticaret platformu se\u00e7in, hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n, fon yat\u0131r\u0131n, \"INO\" sembol\u00fc ile arama yap\u0131n, limit emirleri kullanarak sipari\u015f verin ve pozisyonunuzu d\u00fczenli olarak izleyin."},{"question":"INO hissesinin riskleri nelerdir?","answer":"FDA reddi riski, mali \u00e7\u00f6k\u00fc\u015f, a\u015f\u0131r\u0131 volatilite ve hisse seyrelmesi en \u00f6nemli risklerdir."},{"question":"INO hissesi i\u00e7in fiyat tahmini nedir?","answer":"2025 sonunda 2,50-4,00 $ aras\u0131 beklenirken, FDA onay\u0131 halinde 2026'da 8-18 $ aral\u0131\u011f\u0131 hedeflenmektedir."},{"question":"INO hissesi neden bu kadar volatil?","answer":"\u015eirketin finansal durumu, FDA onay s\u00fcre\u00e7leri ve d\u00fczenleyici geli\u015fmeler hisse fiyat\u0131nda b\u00fcy\u00fck dalgalanmalara neden olmaktad\u0131r."},{"question":"Yeni ba\u015flayanlar INO hissesi i\u00e7in ne yapmal\u0131?","answer":"Portf\u00f6y\u00fcn k\u00fc\u00e7\u00fck bir k\u0131sm\u0131n\u0131 ay\u0131rmal\u0131, Kas\u0131m ay\u0131ndaki kazan\u00e7 raporunu beklemeli, s\u0131k\u0131 stop-loss kullanmal\u0131 ve portf\u00f6y\u00fc \u00e7e\u015fitlendirmelidir."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Inovio Pharmaceuticals, Inc. (INO) Hisseleri Nas\u0131l Al\u0131n\u0131r - Inovio Pharmaceuticals, Inc. (INO) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Inovio Pharmaceuticals, Inc. (INO) Hisseleri Nas\u0131l Al\u0131n\u0131r - Inovio Pharmaceuticals, Inc. (INO) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-20T14:40:46+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Inovio Pharmaceuticals, Inc. (INO) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Inovio Pharmaceuticals, Inc. (INO) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-20T14:40:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/\",\"name\":\"Inovio Pharmaceuticals, Inc. (INO) Hisseleri Nas\u0131l Al\u0131n\u0131r - Inovio Pharmaceuticals, Inc. (INO) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"datePublished\":\"2025-08-20T14:40:46+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"width\":2560,\"height\":1429},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Inovio Pharmaceuticals, Inc. (INO) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Inovio Pharmaceuticals, Inc. (INO) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Inovio Pharmaceuticals, Inc. (INO) Hisseleri Nas\u0131l Al\u0131n\u0131r - Inovio Pharmaceuticals, Inc. (INO) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/","og_locale":"tr_TR","og_type":"article","og_title":"Inovio Pharmaceuticals, Inc. (INO) Hisseleri Nas\u0131l Al\u0131n\u0131r - Inovio Pharmaceuticals, Inc. (INO) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-20T14:40:46+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Inovio Pharmaceuticals, Inc. (INO) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Inovio Pharmaceuticals, Inc. (INO) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-20T14:40:46+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/","name":"Inovio Pharmaceuticals, Inc. (INO) Hisseleri Nas\u0131l Al\u0131n\u0131r - Inovio Pharmaceuticals, Inc. (INO) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","datePublished":"2025-08-20T14:40:46+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","width":2560,"height":1429},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Inovio Pharmaceuticals, Inc. (INO) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Inovio Pharmaceuticals, Inc. (INO) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":341349,"slug":"how-to-buy-inovio-pharmaceuticals","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Inovio Pharmaceuticals, Inc. (INO) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Inovio Pharmaceuticals, Inc. (INO)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/"},"pt_AA":{"locale":"pt_AA","id":341350,"slug":"how-to-buy-inovio-pharmaceuticals","post_title":"Como comprar a\u00e7\u00f5es da Inovio Pharmaceuticals, Inc. (INO) - Investimento em a\u00e7\u00f5es da Inovio Pharmaceuticals, Inc. (INO)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/341351","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=341351"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/341351\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334108"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=341351"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=341351"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=341351"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}